PAC-1 Activates Procaspase-3 in Vitro through Relief of Zinc-Mediated Inhibition

Journal of Molecular Biology

Volumn 388, Issue 1, 2009, Pages 144-158

  Peterson, Quinn P ^a   Goode, David R ^a   West, Diana C ^a   Ramsey, Kara N ^a   Lee, Joy J Y ^a   Hergenrother, Paul J ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

apoptosis; cancer; PAC 1; procaspase 3; zinc

Indexed keywords

DUAL SPECIFICITY PHOSPHATASE 2; PROCASPASE 3; ZINC;

ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CELL CULTURE; CONTROLLED STUDY; DISSOCIATION; DRUG STRUCTURE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; XENOGRAFT;

EID: 63449138094     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2009.03.003     Document Type: Article

References (67)

1. Papadopoulos N., Kinzler K.W., and Vogelstein B. The role of companion diagnostics in the development and use of mutation-targeted cancer therapies. Nat. Biotechnol. 24 (2006) 985-995
2. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
3. Blatt N.B., and Glick G.D. Signaling pathways and effector mechanisms pre-programmed cell death. Bioorg. Med. Chem. 9 (2001) 1371-1384
4. Fischer U., Janicke R.U., and Schulze-Osthoff K. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ. 10 (2003) 76-100
5. Luthi A.U., and Martin S.J. The CASBAH: a searchable database of caspase substrates. Cell Death Differ. 14 (2007) 641-650
6. Timmer J.C., and Salvesen G.S. Caspase substrates. Cell Death Differ. 14 (2007) 66-72
7. Lowe S.W., Cepero E., and Evan G. Intrinsic tumor suppression. Nature 432 (2004) 307-315
8. Igney F.H., and Krammer P.H. Death and anti-death: tumor resistance to apoptosis. Nat. Rev. Cancer 2 (2002) 277-288
9. Vogelstein B., and Kinzler K.W. Achilles' heel of cancer. Nature 412 (2001) 865-866
10. Kirkin V., Joos S., and Zornig M. The role of Bcl-2 family members in tumorigenesis. Biochim. Biophys. Acta 1644 (2004) 229-249
11. Soengas M.S., Capodieci P., Polsky D., Mora J., Esteller M., Opitz-Araya X., et al. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 409 (2001) 207-211
12. Bremer E., van Dam G., Kroesen B.J., de Leij L., and Helfrich W. Targeted induction of apoptosis for cancer therapy: current progress and prospects. Trends Mol. Med. 12 (2006) 382-393
13. Green D.R., and Kroemer G. Pharmacological manipulation of cell death: clinical applications in sight?. J. Clin. Invest. 115 (2005) 2610-2617
14. Fesik S.W. Promoting apoptosis as a strategy for cancer drug discovery. Nat. Rev. Cancer 5 (2005) 876-885
15. Vassilev L.T., Vu B.T., Graves B., Carvajal D., Podlaski F., Filipovic Z., et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303 (2004) 844-848
16. Tovar C., Rosinski J., Filipovic Z., Higgins B., Kolinsky K., Hilton H., et al. Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy. Proc. Natl Acad. Sci. USA 103 (2006) 1888-1893
17. Oltersdorf T., Elmore S.W., Shoemaker A.R., Armstrong R.C., Augeri D.J., Belli B.A., et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435 (2005) 677-681
18. Nguyen J.T., and Wells J.A. Direct activation of the apoptosis machinery as a mechanism to target cancer cells. Proc. Natl Acad. Sci. USA 100 (2003) 7533-7538
19. Li L., Thomas R.M., Suzuki H., De Brabander J.K., Wang X., and Harran P.G. A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death. Science 305 (2004) 1471-1474
20. Sun H., Nikolovska-Coleska Z., Yang C.Y., Xu L., Liu M., Tomita Y., et al. Structure-based design of potent, conformationally constrained Smac mimetics. J. Am. Chem. Soc. 126 (2004) 16686-16687
21. Roy S., Bayly C.I., Gareau Y., Houtzager V.M., Kargman S., Keen S.L.C., et al. Maintenance of caspase-3 proenzyme dormancy by an intrinsic "safety catch" regulatory tripeptide. Proc. Natl Acad. Sci. USA 98 (2001) 6132-6137
22. Grigoriev M.Y., Pozharissky K.M., Hanson K.P., Imyanitov E.N., and Zhivotovsky B. Expression of caspase-3 and -7 does not correlate with the extent of apoptosis in primary breast carcinomas. Cell Cycle 1 (2002) 337-342
23. O'Donovan N., Crown J., Stunell H., Hill A.D., McDermott E., O'Higgins N., and Duffy M.J. Caspase 3 in breast cancer. Clin. Cancer Res. 9 (2003) 738-742
24. Krepela E., Prochazka J., Liul X., Fiala P., and Kinkor Z. Increased expression of Apaf-1 and procaspase-3 and the functionality of intrinsic apoptosis apparatus in non-small cell lung carcinoma. Biol. Chem. 385 (2004) 153-168
25. Fink D., Schlagbauer-Wadl H., Selzer E., Lucas T., Wolff K., Pehamberger H., et al. Elevated procaspase levels in human melanoma. Melanoma Res. 11 (2001) 385-393
26. Estrov Z., Thall P.F., Talpaz M., Estey E.H., Kantarjian H.M., Andreeff M., et al. Caspase 2 and caspase 3 protein levels as predictors of survival in acute myelogenous leukemia. Blood 92 (1998) 3090-3097
27. Putt K.S., Chen G.W., Pearson J.M., Sandhorst J.S., Hoagland M.S., Kwon J.-T., et al. Small molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy. Nat. Chem. Biol. 2 (2006) 543-550
28. Han Z., Hendrickson E.A., Bremner T.A., and Wyche J.H. A sequential two-step mechanism for the production of the mature p17:p12 form of caspase-3 in vitro. J. Biol. Chem. 272 (1997) 13432-13436
29. Stennicke H.R., Jurgensmeier J.M., Shin H., Deveraux Q., Wolf B.B., Yang X., et al. Pro-caspase-3 is a major physiologic target of caspase-8. J. Biol. Chem. 273 (1998) 27084-27090
30. Bose K., Pop C., Feeney B., and Clark A.C. An uncleavable procaspase-3 mutant has a lower catalytic efficiency but an active site similar to that of mature caspase-3. Biochemistry 42 (2003) 12298-12310
31. Feeney B., Pop C., Swartz P., Mattos C., and Clark A.C. Role of loop bundle hydrogen bonds in the maturation and activity of (Pro)caspase-3. Biochemistry 45 (2006) 13249-13263
32. Perry D.K., Smyth M.J., Stennicke H.R., Salvesen G.S., Duriez P., Poirier G.G., and Hannun Y.A. Zinc is a potent inhibitor of the apoptotic protease, caspase-3. A novel target for zinc in the inhibition of apoptosis. J. Biol. Chem. 272 (1997) 18530-18533
33. Stennicke H.R., and Salvesen G.S. Biochemical characteristics of caspases-3, -6, -7, and -8. J. Biol. Chem. 272 (1997) 25719-25723
34. Aiuchi T., Mihara S., Nakaya M., Masuda Y., Nakajo S., and Nakaya K. Zinc ions prevent processing of caspase-3 during apoptosis induced by geranylgeraniol in HL-60 cells. J. Biochem. (Tokyo) 124 (1998) 300-303
35. Chai F., Truong-Tran A.Q., Ho L.H., and Zalewski P.D. Regulation of caspase activation and apoptosis by cellular zinc fluxes and zinc deprivation: a review. Immunol. Cell Biol. 77 (1999) 272-278
36. Maret W., Jacob C., Vallee B.L., and Fischer E.H. Inhibitory sites in enzymes: zinc removal and reactivation by thionein. Proc. Natl Acad. Sci. USA 96 (1999) 1936-1940
37. Charkoudian L.K., and Franz K.J. Fe(III)-coordination properties of neuromelanin components: 5,6-dihydroxyindole and 5,6-dihydroxyindole-2-carboxylic acid. Inorg. Chem. 45 (2006) 3657-3664
38. Truong-Tran A.Q., Grosser D., Ruffin R.E., Murgia C., and Zalewski P.D. Apoptosis in the normal and inflamed airway epithelium: role of zinc in epithelial protection and procaspase-3 regulation. Biochem. Pharmacol. 66 (2003) 1459-1468
39. Shiozaki E.N., Chai J., and Shi Y. Oligomerization and activation of caspase-9, induced by Apaf-1 CARD. Proc. Natl Acad. Sci. USA 99 (2002) 4197-4202
40. Zou H., Yang R., Hao J., Wang J., Sun C., Fesik S.W., et al. Regulation of the Apaf-1/caspase-9 apoptosome by caspase-3 and XIAP. J. Biol. Chem. 278 (2003) 8091-8098
41. Chao Y., Shiozaki E.N., Srinivasula S.M., Rigotti D.J., Fairman R., and Shi Y. Engineering a dimeric caspase-9: a re-evaluation of the induced proximity model for caspase activation. PLoS Biol. 3 (2005) e183
42. Shiozaki E.N., Chai J., Rigotti D.J., Riedl S.J., Li P., Srinivasula S.M., et al. Mechanism of XIAP-mediated inhibition of caspase-9. Mol. Cell 11 (2003) 519-527
43. Juan T.S., McNiece I.K., Argento J.M., Jenkins N.A., Gilbert D.J., Copeland N.G., and Fletcher F.A. Identification and mapping of Casp7, a cysteine protease resembling CPP32 beta, interleukin-1 beta converting enzyme, and CED-3. Genomics 40 (1997) 86-93
44. Lippke J.A., Gu Y., Sarnecki C., Caron P.R., and Su M.S. Identification and characterization of CPP32/Mch2 homolog 1, a novel cysteine protease similar to CPP32. J. Biol. Chem. 271 (1996) 1825-1828
45. Fernandes-Alnemri T., Armstrong R.C., Krebs J., Srinivasula S.M., Wang L., Bullrich F., et al. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc. Natl Acad. Sci. USA 93 (1996) 7464-7469
46. Stennicke H.R., and Salvesen G.S. Catalytic properties of the caspases. Cell Death Differ. 6 (1999) 1054-1059
47. Shi Y. Caspase activation, inhibition, and reactivation: a mechanistic view. Protein Sci. 13 (2004) 1979-1987
48. Denault J.-B., and Salvesen G.S. Human caspase-7 activity and regulation by its N-terminal peptide. J. Biol. Chem. 278 (2003) 34042-24050
49. Scott F.L., Denault J.B., Riedl S.J., Shin H., Renatus M., and Salvesen G.S. XIAP inhibits caspase-3 and -7 using two binding sites: evolutionarily conserved mechanism of IAPs. EMBO J. 24 (2005) 645-655
50. Charkoudian L.K., Pham D.M., and Franz K.J. A pro-chelator triggered by hydrogen peroxide inhibits iron-promoted hydroxyl radical formation. J. Am. Chem. Soc. 128 (2006) 12424-12425
51. Sivaramaiah S., and Reddy P.R. Direct and derivative spectrophotometric determination of zinc with 2,4-dihydroxybenzaldehyde isonicotinoyl hydrazone in potable water and pharmaceutical samples. J. Anal. Chem. 60 (2005) 828-832
52. Likussar W., and Boltz D.F. Theory of continuous variations plots and a new method for spectrophotometric determination of extraction and formation constants. Anal. Chem. 43 (1971) 1265-1272
53. Adair G.S., Bock A.B., and Field H. The hemoglobin system. VI. The oxygen dissociation curve of hemoglobin. J. Biol. Chem. 63 (1925) 259
54. Fahrni C.J., and O'Halloran T.V. Aqueous coordination chemistry of quinoline-based fluorescence probes for the biological chemistry of zinc. J. Am. Chem. Soc. 121 (1999) 11448-11458
55. Carter J.E., Truong-Tran A.Q., Grosser D., Ho L., Ruffin R.E., and Zalewski P.D. Involvement of redox events in caspase activation in zinc-depleted airway epithelial cells. Biochem. Biophys. Res. Commun. 297 (2002) 1062-1070
56. Truong-Tran A.Q., Carter J., Ruffin R.E., and Zalewski P.D. The role of zinc in caspase activation and apoptotic cell death. BioMetals 14 (2001) 315-330
57. Zhao R., Planalp R.P., Ma R., Greene B.T., Jones B.T., Brechbiel M.W., et al. Role of zinc and iron chelation in apoptosis mediated by tachpyridine, an anti-cancer iron chelator. Biochem. Pharmacol. 67 (2004) 1677-1688
58. Donadelli M., Dalla Pozza E., Costanzo C., Scupoli M.T., Scarpa A., and Palmieri M. Zinc depletion efficiently inhibits pancreatic cancer cell growth by increasing the ratio of antiproliferative/proliferative genes. J. Cell. Biochem. 104 (2008) 202-212
59. Hyun H.J., Sohn J.H., Ha D.W., Ahn Y.H., Koh J.Y., and Yoon Y.H. Depletion of intracellular zinc and copper with TPEN results in apoptosis of cultured human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 42 (2001) 460-465
60. Hyun H.J., Sohn J., Ahn Y.H., Shin H.C., Koh J.Y., and Yoon Y.H. Depletion of intracellular zinc induces macromolecule synthesis- and caspase-dependent apoptosis of cultured retinal cells. Brain Res. 869 (2000) 39-48
61. Truong-Tran A.Q., Ruffin R.E., and Zalewski P.D. Visualization of labile zinc and its role in apoptosis of primary airway epithelial cells and cell lines. Am. J. Physiol., Lung Cell. Mol. Physiol. 279 (2000) L1172-L1183
62. Hashemi M., Ghavami S., Eshraghi M., Booy E.P., and Los M. Cytotoxic effects of intra and extracellular zinc chelation on human breast cancer cells. Eur. J. Pharmacol. 557 (2007) 9-19
63. Zalewski P.D., Forbes I.J., and Betts W.H. Correlation of apoptosis with change in intracellular labile Zn(II) using zinquin [(2-methyl-8-p-toluenesulphonamido-6-quinolyloxy)acetic acid], a new specific fluorescent probe for Zn(II). Biochem. J. 296 Pt 2 (1993) 403-408
64. Kania J., Konturek S.J., Marlicz K., Hahn E.G., and Konturek P.C. Expression of survivin and caspase-3 in gastric cancer. Dig. Dis. Sci. 48 (2003) 266-271
65. Yang S., Liu J., Thor A.D., and Yang X. Caspase expression profile and functional activity in a panel of breast cancer cell lines. Oncol. Rep. 17 (2007) 1229-1235
66. Persad R., Liu C., Wu T.-T., Houlihan P.S., Hamilton S.R., Diehl A.M., and Rashid A. Overexpression of caspase-3 in hepatocellular carcinomas. Mod. Pathol. 17 (2004) 861-867
67. Goode D.R., Sharma A.K., and Hergenrother P.J. Using peptidic inhibitors to systematically probe the S1′ site of caspase-3 and caspase-7. Org. Lett. 7 (2005) 3529-3532